 Investors |
|
|
|
|
|
 |
|
|
|
|
| All Releases |
|---|
 |
GeoPharma Announces the Acceptability of Their Largo Cephalosporin Plant
Mar 2, 2010
|
12.6 KB |
|
| |
LARGO, Fla., Mar 2, 2010 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that the FDA Office of Compliance has completed the evaluation of its Largo, Florida manufacturing facility dedicated to the production of Cephalosporin antibiotics and has indicated, based on the adequacy of the Company...
|
|
GeoPharma Announces Fiscal Year 2010 Third Quarter Results Conference Call
Mar 1, 2010
|
13.2 KB |
|
| |
LARGO, Fla., Mar 1, 2010 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") is hosting a conference call on March 2, 2010 at 11 a.m. ET to discuss the Fiscal Year 2010 Third Quarter Results that were previously announced on Feb. 23, 2010. During the call, the company will discuss the Fiscal Year Third Quarter r...
|
|
GeoPharma Announces Fiscal Year 2010 Third Quarter Results and Conference Call
Feb 23, 2010
|
16.7 KB |
|
| |
LARGO, Fla., Feb 23, 2010 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 third quarter which ended December 31, 2009, with revenues totaling $2,766,203 from continuing operations and a net loss basic and diluted of $(0.19) cents per share versus ($0.26) ce...
|
|
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Stockholders' Equity Requirement
Dec 3, 2009
|
11.2 KB |
|
| |
LARGO, Fla., Dec 3, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a NASDAQ Staff Deficiency Letter on November 25th, 2009 indicating that the Company does not comply with the Minimum Stockholders' Equity requirement for continued listing set forth in NASDAQ Listing Rule 555...
|
|
GeoPharma Announces Fiscal Year 2010 Second Quarter Results and Conference Call
Nov 24, 2009
|
17.3 KB |
|
| |
LARGO, Fla., Nov 24, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 second quarter which ended September 30, 2009, with revenues totaling $3,407,590 from continuing operations and a net loss from continuing and discontinued operations of .23 cents per...
|
|
GeoPharma Announces Fiscal Year 2010 Second Quarter Results Release Date and Conference Call
Nov 13, 2009
|
13.0 KB |
|
| |
LARGO, Fla., Nov 13, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it will host a conference call to discuss the fiscal year 2010 second quarter, which ended September 30, 2009. Financial results will be released before the market opens on Tuesday, November 17, 2009 with the confe...
|
|
GeoPharma Receives Guidance From NASDAQ Regarding Minimum Bid Price Requirement
Sep 18, 2009
|
11.6 KB |
|
| |
LARGO, Fla., Sep 18, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today it received a Nasdaq Staff Deficiency Letter on September 15th, 2009 indicating that the Company does not comply with the Minimum Bid Price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2). ...
|
|
GeoPharma Announces Settlement of Baltimore Beta-Lactam Antibiotics Facility Litigation
Sep 8, 2009
|
12.9 KB |
|
| |
LARGO, Fla., Sep 8, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it, through its subsidiary, American Antibiotics, LLC (collectively, "AA Parties") has reached agreement with Consolidated Pharmaceutical Group, Inc. ("CPG"), the directors of CPG and two other individuals acting on...
|
|
GeoPharma Announces Fiscal Year 2010 First Quarter Results and Conference Call
Aug 17, 2009
|
17.4 KB |
|
| |
LARGO, Fla., Aug 17, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the results of its fiscal year 2010 first quarter.
Commenting on the quarter GeoPharma CEO Mihir Taneja stated, "Our first quarter results reveal that the transition of our business model is taking hold. The strateg...
|
|
GeoPharma Announces Fiscal Year 2010 First Quarter Results Release Date and Conference Call
Aug 13, 2009
|
12.8 KB |
|
| |
LARGO, Fla., Aug 13, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it will host a conference call to discuss the fiscal year 2010 first quarter, which ended June 30, 2009. Financial results will be released before the market opens on Monday, August 17, 2009 with the conference cal...
|
|
CORRECTION -- GeoPharma Announces Fiscal Year 2009 Fourth Quarter and Year End Results
Jul 1, 2009
|
11.3 KB |
|
| |
LARGO, Fla., Jul 1, 2009 (GlobeNewswire via COMTEX News Network) -- In a release issued by GeoPharma, Inc. (Nasdaq:GORX) on June 30, 2009 under the same headline, please note that the Pharmaceutical revenues line item wasn't included, causing the numbers for the remaining line items to be incorrect. The corrected table follows:
...
|
|
GeoPharma Announces Fiscal Year 2009 Fourth Quarter and Year End Results
Jun 30, 2009
|
16.1 KB |
|
| |
LARGO, Fla., Jun 30, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today its fiscal year 2009 year end results for the period ended March 31, 2009, reporting total revenues of $63,020,060 for the year representing a increase of approximately 14.6 % versus the same period a year ago. Revenues...
|
|
GeoPharma Subsidiary 'BOSS' Announces Interview Article About WEC(r) Featherweight Champion Mike Brown On Its Bossonline.net Website
Mar 23, 2009
|
11.3 KB |
|
| |
LARGO, Fla., Mar 23, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that its wholly-owned subsidiary, Bob O'Leary Health Food Distributor Co., Inc. (BOSS), has added an interview article to its BOSS Online website. The article focuses on the life of World Extreme Cagefighting(r) Feather...
|
|
GeoPharma Announces Fiscal Year 2009 Third Quarter Earnings
Feb 11, 2009
|
18.5 KB |
|
| |
LARGO, Fla., Feb 11, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced its fiscal year 2009 third quarter results for the period ended December 31, 2008, reporting revenues of $13,112,972 for the quarter representing a decrease of approximately 28% versus the same period a year ago. Revenues for...
|
|
GeoPharma Announces Fiscal Year 2009 Third Quarter Earnings Release Date and Conference Call
Feb 4, 2009
|
13.4 KB |
|
| |
LARGO, Fla., Feb 4, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it will host a conference call to discuss the results of its fiscal year 2009 third quarter which ended December 31, 2008. Financial results will be released after the market closes on Wednesday, February 11, 2009 w...
|
|
GeoPharma Subsidiary 'BOSS' Announces Interview Article About UFC(r) Fighter Thiago Alves On Its Bossonline.net Website
Jan 30, 2009
|
12.6 KB |
|
| |
LARGO, Fla., Jan 30, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that its wholly-owned subsidiary, Bob O'Leary Health Food Distributor Co., Inc. (BOSS), has added an interview article on UFC(r) fighter Thiago Alves on its freshly redesigned BOSS Online website. The article focuses on...
|
|
GeoPharma Announces Sale of Majority Ownership in its Ovarian Cancer Business, Company to Focus on Core Business
Jan 26, 2009
|
13.0 KB |
|
| |
LARGO, Fla., Jan 26, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today the signing of an agreement with Trident Biotech, Inc. for the purchase of a majority stake in the Company's Ovarian Cancer business. GeoPharma receives $2.5 million in cash and notes and will maintain forty percent own...
|
|
GeoPharma Announces Settlement of Clarinex(r) (Desloratadine) ANDA Patent Litigation With Schering and Sepracor
Jan 20, 2009
|
13.4 KB |
|
| |
LARGO, Fla., Jan 20, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today that it has reached agreement with the Schering Corporation ("Schering"), and Sepracor, Inc. and the University of Massachusetts (collectively, "Sepracor") settling all Hatch-Waxman litigation relating to Desloratadine ...
|
|
GeoPharma Announces Corporate Restructuring and Third Quarter Earnings Release Date
Jan 13, 2009
|
14.1 KB |
|
| |
LARGO, Fla., Jan 13, 2009 (GlobeNewswire via COMTEX News Network) -- GeoPharma, Inc. (Nasdaq:GORX) (the "Company") announced today a strategic restructuring plan that is intended to improve its financial performance by consolidating operations, reducing head count and lowering SG&A. The plan will allow the Company to maintain the focus of its core ...
|
|
GeoPharma Announces Revenues Increase By 166% in the Second Quarter of Fiscal Year 2009
Nov 13, 2008
|
20.9 KB |
|
| |
LARGO, Fla., Nov 13, 2008 (BUSINESS WIRE) -- GeoPharma, Inc. (NASDAQ:GORX) (the "Company") announced its Fiscal Year 2009 second quarter results for the period ended September 30, 2008, reporting revenues of $16,039,751 representing a 166% increase over the Fiscal Year 2008 second quarter results. The Company recorded a net loss of ($3,888,580) or ...
|
|
|
 = add release to Briefcase |
|
|
Press Releases